Incidence of Diabetes in Colorectal Cancer Survivors

Journal of the National Cancer Institute
Simron SinghL L Lipscombe

Abstract

A higher risk of colorectal cancer (CRC) in patients with diabetes has been well documented. However, little is known regarding diabetes incidence in CRC survivors. This may have substantial impact on CRC survivorship care as well as enhancing the understanding of the interplay between the two diseases. We explored whether the incidence of diabetes was higher among patients with CRC than matched control subjects. Using population-based data from Ontario, Canada, we generated a dataset comprising 39 707 incident CRC cases and 198 535 age- and sex-matched control subjects (1:5) dating from April 2002 to March 2010. We used cause-specific hazard models to estimate the hazard ratios (HRs) for diabetes overall and in subgroups stratified by receipt of systemic chemotherapy, diagnosis of metastatic disease, and site of cancer. During a mean follow-up of 4.81 years, the association between CRC and diabetes varied: The rate of developing diabetes was 53% higher among CRC patients compared with control subjects in the first year postdiagnosis (HR = 1.53, 95% confidence interval [CI] = 1.42 to 1.64) and remained increased by 19% in the fifth year postdiagnosis (HR = 1.19, 95% CI = 1.05 to 1.35). Findings were similar in subgroups of pati...Continue Reading

References

Sep 1, 1990·American Journal of Epidemiology·G A ColditzF E Speizer
Mar 1, 1995·Annals of Internal Medicine·E GiovannucciW C Willett
Jan 1, 1996·Cancer Causes & Control : CCC·J D Potter
Feb 12, 1997·JAMA : the Journal of the American Medical Association·J SalmerónW C Willett
Apr 1, 1997·Diabetes Care·J SalmerónW C Willett
Jul 2, 1997·Journal of the National Cancer Institute·M E MartínezG A Colditz
Mar 27, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·G CastiglioneS Ciatto
Mar 5, 2004·International Journal of Cancer. Journal International Du Cancer·Jessie Satia-AboutaRobert S Sandler
Apr 23, 2005·BMJ : British Medical Journal·Muhammad MamdaniGeoffrey M Anderson
Nov 17, 2005·Journal of the National Cancer Institute·Susanna C LarssonAlicja Wolk
Jan 19, 2006·Journal of the National Cancer Institute·Adeline SeowMimi C Yu
Jun 1, 2006·The Journal of Clinical Endocrinology and Metabolism·James B MeigsRalph B D'Agostino
Jul 20, 2006·Journal of the National Cancer Institute·Sandra L Wong
Dec 14, 2006·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Til StürmerRobert J Glynn
Jul 24, 2008·Journal of Cancer Survivorship : Research and Practice·Charles J StavaRena Vassilopoulou-Sellin
Mar 26, 2009·Journal of the National Cancer Institute·Tamas HickishDavid Kerr
Jun 6, 2009·American Journal of Epidemiology·Bryan LauStephen J Gange
Jul 22, 2009·Endocrine-related Cancer·Paolo VigneriRiccardo Vigneri
Nov 20, 2009·Nature Reviews. Endocrinology·Riccardo Vigneri
Apr 13, 2010·Cancer Causes & Control : CCC·Andrew FloodArthur Schatzkin
Jun 10, 2010·British Journal of Cancer·J HeC A Haiman
Sep 6, 2011·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Heike U KrämerHermann Brenner
Sep 14, 2011·The American Journal of Gastroenterology·Hiroki YuharaPatricia A Buffler
Sep 14, 2011·International Journal of Cancer. Journal International Du Cancer·Jin Ha LeeWon Ho Kim
Dec 3, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Chia-Hsuin ChangK Arnold Chan
Feb 4, 2012·Digestive Diseases and Sciences·Lei Sun, Shiying Yu
Feb 22, 2012·Digestive Diseases and Sciences·Longying DengLizong Shen
Apr 6, 2012·Diabetologia·J A JohnsonUNKNOWN Diabetes and Cancer Research Consortium
Apr 25, 2012·Cancer Causes & Control : CCC·Adedayo A OnitiloSuhail A Doi
May 4, 2012·Cancer Causes & Control : CCC·Adedayo A OnitiloSuhail A Doi

❮ Previous
Next ❯

Citations

Jan 31, 2017·Current Opinion in Gastroenterology·Andrea Cercek, Peter R Holt
Mar 29, 2019·Journal of the National Cancer Institute·Makenzie L HawkinsMia Hashibe
Jun 21, 2019·The Journal of Clinical Endocrinology and Metabolism·Jesper F ChristensenPernille Hojman
Aug 7, 2017·Medical Oncology·Umbelina Soares BorgesPedro Vitor Lopes-Costa
Nov 14, 2019·Endocrine Reviews·Iliana C Lega, Lorraine L Lipscombe
Oct 28, 2019·Cancer Causes & Control : CCC·Cindy K BlairAnita Y Kinney
Aug 5, 2020·Journal of Adolescent and Young Adult Oncology·Andreana N HolowatyjCornelia M Ulrich
Aug 15, 2020·Journal of Cancer Survivorship : Research and Practice·Beth A GlennRoshan Bastani
Dec 3, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gadi ShlomaiEmily Jane Gallagher
Mar 14, 2017·Journal of Diabetes Research·Jiancheng LiuJie Ma
Mar 5, 2021·Contemporary Clinical Trials Communications·Cindy K BlairWendy Demark-Wahnefried
Apr 4, 2021·International Journal of Molecular Sciences·Steffen H RaunLykke Sylow
Oct 11, 2017·Metabolism: Clinical and Experimental·Marco GalloAnnamaria Colao
Apr 17, 2021·Frontiers in Oncology·Yuqian FengCihui Chen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.